NCT00520767 2023-12-22
Bortezomib, Melphalan, and Dexamethasone in Treating Patients With Primary Amyloidosis or Light Chain Deposition Disease
Barbara Ann Karmanos Cancer Institute
Phase 2 Completed
Barbara Ann Karmanos Cancer Institute
OHSU Knight Cancer Institute
SWOG Cancer Research Network
Vanderbilt-Ingram Cancer Center